Beruflich Dokumente
Kultur Dokumente
com
Review
ABSTRACT
Early onset neonatal sepsis is persistently associated with
poor outcomes, and incites clinical practice based on the
fear of missing a treatable infection in a timely fashion.
Unnecessary exposure to antibiotics is also hazardous.
Diagnostic dilemmas are discussed in this review, and
suggestions offered for practical management while
awaiting a more rapidly available gold standard test; in
an ideal world, this test would be 100% sensitive and
100% specic for the presence of organisms.
INTRODUCTION
Culture-proven early onset neonatal infection is
conrmed in <1%1 of admissions to neonatal
units, yet accounts for up to 16%2 of all neonatal
mortality and contributes to signicant morbidity.
Culture-negative infection occurs more frequently.
Fear of infection results in the majority of newborns who are given antibiotics, receiving them
unnecessarily.3 The hazards are beyond the fact that
antibiotic therapy drives antibiotic resistance.
Antibiotics also disrupt maternal and the newborns
faecal ora, and in so doing, disrupt normal
development of the nascent immune system.4
Neonatologists are constrained by the availability of
insufciently sensitive and specic microbiological
diagnostic tools, which would allow more judicious
antibiotic prescribing.
In recognition of the number of dilemmas
regarding diagnosis and management of early onset
neonatal infection which contribute to variations in
practice, the UK National Institute for Health and
Care Excellence (NICE) commissioned a clinical
guideline development group (CGDG), consisting
of a wide range of stakeholders, to systematically
review all available evidence and develop a guideline which would prioritise the treatment of sick
newborn babies and use antibiotics more selectively.5 Recently published evidence has strengthened the original NICE CGDG reccomendations.6
Bedford Russell AR, et al. Arch Dis Child Fetal Neonatal Ed 2015;100:F350F354. doi:10.1136/archdischild-2014-306193
Review
have demonstrated that a risk-factor-based approach to prevention of GBS is limited, with frequent missed opportunities for
prevention of GBS sepsis when risk factors are present.10 11
DIAGNOSIS OF EONS
Early diagnosis of EONS is challenging because clinical
characteristics are non-specic and difcult to differentiate from
MICROBIAL CULTURE
The gold standard for diagnosing infection is, historically, a
positive blood or cerebrospinal uid (CSF) culture with a
minimum reporting delay of 3648 h. Microbial cultures suffer
from low sensitivity and specicity: a negative blood culture
result is almost inevitable for a large proportion of blood cultures because of the submission of inadequate volumes of blood,
and only one culture being drawn.15 16 A false positive culture
of CoNS is common,1 making diagnosis of EONS using the historical gold standard, a challenge.17
Bedford Russell AR, et al. Arch Dis Child Fetal Neonatal Ed 2015;100:F350F354. doi:10.1136/archdischild-2014-306193
F351
Review
Box 3 Summary of key points regarding new evidence
reviewed for National Institute for Health and Care
Excellence Antibiotics for early onset neonatal infection
guideline,6 with no potential impact on guidance
Key Points
Risk factor for infection and clinical indicators of possible
infection
Epidural analgesia may be a risk factor for early onset
neonatal fever, irrespective of intrapartum fever, but is not
associated with a higher incidence of neonatal infection.
Investigations before starting antibiotics in the baby
Full blood count indices may not be sufciently sensitive to
rule out early onset infection in neonates.
Serum procalcitonin concentration: the heterogeneity of
available evidence on use of procalcitonin concentrations,
prevents conclusions regarding the value of this marker.
Antibiotics for suspected infection
Gentamicin dosing 5 mg/kg every 3648 h according to
gentamicin level at 22 h can achieve effective and safe
gentamicin levels in very preterm as well as term babies.
Duration of antibiotic treatment
Serial C-reactive protein (CRP) measurements Antibiotic
treatment can safely be stopped at 48 h in culture-negative
very low birth weight infants who have CRP concentrations
<10 mg/L at presentation and at 48 h.
LUMBAR PUNCTURE
A lumbar puncture (LP) should be performed to obtain CSF
prior to starting antibiotics if it is thought safe to do so, and
there is a strong clinical suspicion of infection, or there are clinical symptoms or signs suggestive of meningitis.5 Antibiotic
therapy should not be delayed in order to perform an LP.
In a retrospective case review of infants who developed meningitis in the rst 72 h of life, selective criteria for performing
an LP would have delayed or missed the diagnosis of meningitis
in up to 37% of those evaluated. Those with meningitis
included preterm babies with respiratory distress syndrome
(RDS), asymptomatic term infants with positive blood cultures
as well as term infants with no neurological signs or symptoms,
and negative blood cultures.20 Positive CSF cultures, despite
negative blood cultures, have also been reported for very low
birthweight neonates, without specic neurological clinical manifestations, undergoing screens for suspected late-onset sepsis,
and support a lower threshold for performing an LP as part of a
late-onset sepsis screen.20
Pronounced variation in performance of LP for EONS, even
when adjusting for clinical conditions that would prompt LP,
have been reported in the USA21 22 and may also be a feature in
the UK in spite of NICE guidance.
Bedford Russell AR, et al. Arch Dis Child Fetal Neonatal Ed 2015;100:F350F354. doi:10.1136/archdischild-2014-306193
Review
EVALUATION OF DIAGNOSTIC METHODS
Leucocyte indexes and C-reactive protein
CRP concentrations may be normal in the early stages of infection,3 and values are subject to physiological variation during
the rst few days of life limiting the use of single values.
Following antigenic stimulation, it takes at least 12 h for a CRP
level to become raised;27 serial measurements in the rst 24
48 h of symptoms increases the test sensitivity, and normal CRP
values during this period have a 99% negative predicted value
for diagnosis of infection.28 The CRP should be measured at
presentation and again after 1824 h in order to facilitate decisions regarding LP (if initial CRP >10 mg/L), and decision
making at 36 h, regarding duration of antibiotic therapy.5
Studies including two systematic reviews of the likelihood
ratios for leucocyte indexes and CRP to predict sepsis have all
concluded that there is too much heterogeneity within the
studies and no such ideal test or combination of tests.29 30
Leucopenia and neutropenia, as well as high immature to total
neutrophil ratio (I:T ratio) are undoubtedly associated with
increasing odds of infection (ORs 5.38, 6.84 and 7.90, respectively); however, the test sensitivities for detection of sepsis are
low.31 The combination of two normal I:T ratios within 24 h
and a negative blood culture has been suggested as indicative of
a non-infected neonate, and may be a contributory marker to
assist with the decision to stop antibiotics.32 Having reviewed
the more recent evidence, NICE evidence update advisory
group (NICE EUAG) does not recommend full blood count for
the diagnosis of EONS as the indices are insufciently sensitive
to exclude EONS6 (box 2).
Serum procalcitonin
Procalcitonin (PCT) is the prehormone of calcitonin, normally
secreted by thyroid C-cells, and rises within 36 h of exposure
to infection. It has been suggested that elevated serum PCT concentrations are more sensitive and specic in the differentiation
between neonatal infection and inammation than CRP and
may also differentiate between bacterial and viral infection. In a
meta-analysis of 16 studies (1959 neonates), the sensitivity and
specicity for diagnosing infection were 81% and 79%, respectively.33 Limitations of the evidence included variation in denition of neonatal sepsis, differences in age and gestation of
neonates and a high level of statistical heterogeneity among
studies analysed. Hence, NICE EUAG concluded that the value
of PCT in diagnosis of infection requires further research, and
PCT concentration cannot be recommended within the current
guideline (box 3).
Antimicrobial therapy
Antibiotic therapy drives antibiotic resistance and also alters the
types of colonising microbial ora, especially in the gut leading
to skewing of immune development. E coli EONS has, at best,
remained stable in the USA, but approximately 82% of E coli
isolates are resistant to amoxicillin or gentamicin in preterm
infants.2 Because gut ora drive the nascent immune system,
peripartum antibiotic exposure is increasingly recognised as a
Antimicrobial stewardship
Antimicrobial stewardship (AMS) refers to the coordinated interventions to prescribe and measure the most appropriate,
pathogen-specic, narrow-spectrum drug regimen, dose, duration of therapy and route of administration.36 Department of
health guidance provides an outline of evidence-based AMS in
the secondary healthcare setting promoting a Start SmartThen
Focus approach for all antibiotic prescriptions (box 4). Elements
of an AMS should also include an assessment of acute-trust AMS
activities using the self-assessment toolkit, a trust AMS
Bedford Russell AR, et al. Arch Dis Child Fetal Neonatal Ed 2015;100:F350F354. doi:10.1136/archdischild-2014-306193
F353
Review
management team/committee, ward-focused antimicrobial teams
and evidence-based antimicrobial-prescribing guidelines. Some
recommendations are not applicable to the neonatal context, for
example, changing intravenous to oral antibiotics at the nearest
opportunity, however, neonatal-specic recommendations have
previously been published in this journal37 along with broader
guidelines on managing and preventing Gram-negative infections
in neonatal units.38
The tension between the need to investigate a baby at risk of
EONS and to prescribe antibiotics promptly, versus the fact that
most newborn babies given antibiotics do not have infection but
become exposed to the risks of antimicrobial therapy, has been
recognised by NICE. Exposure to antibiotics must be minimised
safely. NICE Quality Standards Advisory Committee and Project
Team are developing quality standards with the aim of reducing
infant mortality, reducing admissions and readmissions to neonatal
units, maternity and neonatal length of stay and improving neonatal neurological and auditory development. Implementation of
NICE antibiotics for neonatal infection quality standards are
anticipated to shape future neonatal antibiotic prescribing practice
from birth to 28 days of life in the UK, and likely beyond.
SUMMARY
The main diagnostic dilemmas in managing EONS centre on
the lack of a rapid and reliable test, which is 100% specic and
sensitive for presence of microbes in sterile sites. Recent evidence has been reviewed and does not alter NICE guidelines,
which were developed using robust methodology and which
should be used to manage babies at risk and with clinical indicators of EONS. All neonatal units must adopt an AMS programme; while antibiotics can be life saving, they are by no
means harmless to those who do not need them.
Contributors ARBR wrote the rst and nal drafts. RK conducted an extensive
literature review and updated the appropriate sections.
Competing interests None.
Provenance and peer review Commissioned; externally peer reviewed.
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
REFERENCES
1
2
3
4
5
6
7
8
10
F354
30
31
32
33
34
35
36
37
38
Bedford Russell AR, et al. Arch Dis Child Fetal Neonatal Ed 2015;100:F350F354. doi:10.1136/archdischild-2014-306193
doi: 10.1136/archdischild-2014-306193
Updated information and services can be found at:
http://fn.bmj.com/content/100/4/F350
These include:
References
Email alerting
service
This article cites 34 articles, 13 of which you can access for free at:
http://fn.bmj.com/content/100/4/F350#BIBL
Receive free email alerts when new articles cite this article. Sign up in the
box at the top right corner of the online article.
Notes